Clinical Trial Update: Enoxaparin as Treatment for Vulvodynia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating enoxaparin as a treatment for vulvodynia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvodynia

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Western Galilee Hospital-Nahariya | Conditions: Vulvodynia | Phase 2 | Status: COMPLETED